HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--May 15, 2006--Nymox Pharmaceutical Corporation (NASDAQ: NYMX - News) announced today its financial results for the first quarter of 2006. Nymox reported a net loss of $1,059,246 or $0.04 per share for the quarter ending March 31, 2006, compared to $957,677, or $0.04 per share for the same period in 2005. Product sales amounted to $95,259 for the first quarter of 2006, compared to $101,494 for the same period in 2005. Nymox currently has $9.75 million in financing available from its most recent October 21, 2005 financing. The weighted, diluted average number of common shares at March 31, 2006 was 26,999,213, compared to 25,630,585 at March 31, 2005.
